ACE1831 Clinical Trials
2 recruitingDrug
Phase 12Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
Acepodia Biotech, Inc.30 enrolled3 locationsNCT07061938
Recruiting
Phase 1
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
B-cell Lymphoma
Acepodia Biotech, Inc.42 enrolled13 locationsNCT05653271